Your browser doesn't support javascript.
loading
WSB1 promotes tumor metastasis by inducing pVHL degradation.
Kim, Jung Jin; Lee, Seung Baek; Jang, Jinsung; Yi, Sang-Yeop; Kim, Sun-Hyun; Han, Sang-Ah; Lee, Jong-Min; Tong, Seo-Yun; Vincelette, Nicole D; Gao, Bowen; Yin, Ping; Evans, Debra; Choi, Dong Wook; Qin, Bo; Liu, Tongzheng; Zhang, Haoxing; Deng, Min; Jen, Jin; Zhang, Jun; Wang, Liewei; Lou, Zhenkun.
Afiliação
  • Kim JJ; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Lee SB; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Jang J; Division of Pulmonary and Critical Care Medicine, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Yi SY; Department of Pathology, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon 404-834, Republic of Korea;
  • Kim SH; Department of Family Medicine, International St. Mary's Hospital, College of Medicine, Catholic Kwandong University, Incheon 404-834, Republic of Korea;
  • Han SA; Department of Surgery, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;
  • Lee JM; Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;
  • Tong SY; Department of Obstetrics and Gynecology, School of Medicine, Kyung Hee University, Seoul 130-701, Republic of Korea;
  • Vincelette ND; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Gao B; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Yin P; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Evans D; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA; Mayo Graduate School, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Choi DW; Department of Biological Sciences, Sungkyunkwan University, Suwon 440-746, Republic of Korea;
  • Qin B; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Liu T; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Zhang H; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Deng M; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Jen J; Division of Pulmonary and Critical Care Medicine, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Zhang J; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
  • Wang L; Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota 55905, USA;
  • Lou Z; Division of Oncology Research, Mayo Clinic, Rochester, Minnesota 55905, USA;
Genes Dev ; 29(21): 2244-57, 2015 Nov 01.
Article em En | MEDLINE | ID: mdl-26545811
ABSTRACT
The von Hippel-Lindau tumor suppressor pVHL is an E3 ligase that targets hypoxia-inducible factors (HIFs). Mutation of VHL results in HIF up-regulation and contributes to processes related to tumor progression such as invasion, metastasis, and angiogenesis. However, very little is known with regard to post-transcriptional regulation of pVHL. Here we show that WD repeat and SOCS box-containing protein 1 (WSB1) is a negative regulator of pVHL through WSB1's E3 ligase activity. Mechanistically, WSB1 promotes pVHL ubiquitination and proteasomal degradation, thereby stabilizing HIF under both normoxic and hypoxic conditions. As a consequence, WSB1 up-regulates the expression of HIF-1α's target genes and promotes cancer invasion and metastasis through its effect on pVHL. Consistent with this, WSB1 protein level negatively correlates with pVHL level and metastasis-free survival in clinical samples. This work reveals a new mechanism of pVHL's regulation by which cancer acquires invasiveness and metastatic tendency.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Regulação Neoplásica da Expressão Gênica / Proteína Supressora de Tumor Von Hippel-Lindau / Metástase Neoplásica Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas / Regulação Neoplásica da Expressão Gênica / Proteína Supressora de Tumor Von Hippel-Lindau / Metástase Neoplásica Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article